Pharmaceuticals and Biotech | Media Room

Press Release Aug 30, 2022

Leadgene Utilizes LEADSPHERE™ Lyophilization Technology to Make Reagents Stable for Long-Term Logistics

Press Release Aug 24, 2022

ReachBio and abc biopply Partner to Intensify Support for De-Risking Pharma's Drug Development Process

Seattle-based primary cell biology CRO ReachBio and Swiss biotech abc biopply announced today a partnership to jointly co-market their preclinical test models. The two companies plan to support their clients with an even more predictive assay portfolio to further increase the efficiency of their drug discovery and development process. Read More

Press Release Aug 16, 2022

With 3Brain AG's Accura-3D microchip, a first-in-class cell-electronic interface enters the market

In collaboration with Swiss precision manufacturer CSEM, 3Brain AG has announced an exciting 3D microchip for their brain-on-chip portfolio. This first-in-class cell-electronic interface technology will allow scientists to study the complexity of 3D cellular networks at unrivalled scale and precision - and to gain novel mechanistic insights into the inner workings of the most complex structure in the universe: the human brain. Read More

Press Release Aug 15, 2022

Cambridge Isotope Laboratories Appoints John Bakke as Vice President of Finance

Press Release Aug 10, 2022

MyFreePharmacy Offers Relief From Prescription Drug Costs Currently Rising at 3X Inflation of Other Goods

Press Release Aug 5, 2022

Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™. Read More

Press Release Aug 1, 2022

The Fighting for Kaiden Foundation and rareLife Solutions Announce New Partnership in Support of oneSMAvoice.com

Press Release Jul 22, 2022

Taucoin and Golden Ally Join Together to Launch the AQP Water™ Project

Press Release Jul 21, 2022

Epygenix Therapeutics to Participate in RW Baird's Biotech Discovery Series

Press Release Jul 20, 2022

Clinical Outcomes Solutions and Genesis Research Announce Innovative Partnership

Collaboration provides an industry-leading offering for Life Sciences Companies Read More

Press Release Jul 20, 2022

PointCross Releases eDataValidator for SDTM, ADaM, SEND, and Define.XML Conformance to Prevailing FDA, CDISC, and PMDA Rules

Integrated QC dashboard and unlimited validation cycles for interim and final datasets creates industry's most user-friendly validator Read More

Press Release Jul 19, 2022

Pharma Solutions Launches Suspicious Order Monitoring Product for DEA Federal Compliance

Press Release Jul 19, 2022

RxCelerate Launch RxNfinity™: A Next-Generation Machine Learning-Enabled Small Molecule Discovery Platform

World-first as adaptive chemical space is launched as a service Read More

Press Release Jul 19, 2022

Dennis Wong Joins ANANDA Scientific Inc. Board of Directors

Press Release Jul 19, 2022

Dennis Wong Joins ANANDA Scientific's Board of Directors

Press Release Jul 12, 2022

Nilogen and Scailyte Are Joining Forces to Find the 'Right' Treatment for Every Patient

Press Release Jul 12, 2022

Elixiron Immunotherapeutics Receives Grant From the Alzheimer's Association to Trial Microglia-Targeting Immunotherapy

Press Release Jul 12, 2022

Selux Diagnostics Receives $8.0 Million in Additional Funding to Redefine Speed in Microbiology Laboratory Testing

Latest milestone brings the Selux Next-Generation Phenotyping (NGP) platform one step closer to impacting patient care with same-shift Antibiotic Susceptibility Testing (AST). Read More

Press Release Jul 6, 2022

CaaMTech Collaborates With the Alexander Shulgin Research Institute to Study Shulgin Compounds

CaaMTech will help carry on Dr. Alexander Shulgin's legacy by developing ASRI's novel compounds Read More

Press Release Jul 1, 2022

Enalare Therapeutics Receives a National Institutes of Health (NIH) Grant Award

Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Further Development of ENA001, an Agnostic Respiratory Stimulant Read More

Press Release Jun 28, 2022

Circuit Clinical and Pottstown Medical Specialists Inc. (PMSI) Bring Clinical Research to 180K+ Patients Across Greater Northwest Philadelphia Region

Patients from Montgomery, Berks, and Chester Counties will now have access to clinical trials managed by Labcorp Read More

Press Release Jun 24, 2022

Jeanne Hecht Joins Pro-ficiency Board of Directors

Press Release Jun 22, 2022

Announcing the Release of MiXCR 4.0, a Powerful Tool for Immunome Profiling

Press Release Jun 21, 2022

New Alzheimer's Treatment on Horizon as Dementia Reversed for First Time in Dogs

Australian biotech Skin2Neuron Pty Ltd (S2N) has achieved what no one has to date - reversal of a dementia-like syndrome in a natural animal form of Alzheimer's disease. Read More

Press Release Jun 21, 2022

Ferrer Brings ALSton the Dragon to Life to Raise Awareness of ALS

This is the new fantasy creature from the Phantasticals campaign that Ferrer has relaunched, coinciding with Global Amyotrophic Lateral Sclerosis (ALS) Awareness Day, on June 21. The aim is to raise public awareness of this rare, neurodegenerative, progressive disease that affects the motor neurons in the brain. Ferrer is leading the ADORE Phase III clinical trial to evaluate the safety and efficacy of the investigational drug FNP122 in the treatment of ALS. Read More

Press Release Jun 20, 2022

Bron Kisler Joins Nurocor as SVP Customer Alliances and Partnerships

Globally recognized leader in international standards development joins the leader in digitalized clinical development. Read More

Press Release Jun 15, 2022

A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris. Read More

Press Release Jun 14, 2022

Actinogen Announces Phase 2 Trials in Alzheimer's Disease and Depression

Treatment in sight for over 25 million Americans after new clinical trial confirms safety and cognitive enhancement activity of low, once-a-day doses of Xanamem Read More

Press Release Jun 9, 2022

Robin Newman Joins Pro-ficiency Board of Directors

Press Release Jun 8, 2022

Enalare Therapeutics Announces Positive Topline Results With ENA001 in a Propofol Induced Respiratory Depression Study

ENA001, an Agnostic Respiratory Stimulant, Successfully Achieved the Study Primary Endpoint and Was Shown to Be Safe and Well Tolerated Read More

Press Release Jun 7, 2022

AnaBios Closes Financing With Ampersand Capital Partners

Press Release Jun 6, 2022

Qualis Innovations Inc. Becomes Fully Reporting Company

Press Release Jun 2, 2022

Dr. Jeffrey Kasher Joins Pro-Ficiency Board of Directors

Press Release Jun 1, 2022

JM Health Rebrands as Veranova Following Sale to Altaris Capital Partners

Press Release May 20, 2022

University Gastroenterology Partners With Virgo Surgical Video Solutions to Reimagine IBD Clinical Trial Recruitment

Will use AI to identify and enroll the best candidates Read More

Press Release May 19, 2022

Recardio's Phase 2 Results Will Be Presented as Latebreaker at World Congress on Heart Failure 2022 in Madrid

Recardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction will be presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congress on Acute Heart Failure 2022 in Madrid. Read More

Press Release May 12, 2022

Genzada Pharmaceuticals Opens Phase 1B Metastatic Breast Cancer Trial

Press Release May 11, 2022

Ki Young Sohn, CEO of Enzychem Lifesciences Honored by World Biz Magazine Leadership Awards With 'Top 100 Innovation CEO' Award

ENZYCHEM LIFESCIENCES' CHAIRMAN & CEO RECEIVES "TOP 100 INNOVATION CEO OF 2022 AWARD". Read More

Press Release May 10, 2022

InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization

Press Release May 9, 2022

Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients

Press Release May 9, 2022

Wellgistics LLC Announces Acquisition of American Pharmaceutical Ingredients LLC, Dba American Pharmaceutical Distributors (APD)

Wellgistics' Founder Brian Norton today announced the acquisition of Detroit-based Manufacturing and Distribution companies API and APD. Read More

Press Release Apr 26, 2022

Concentric Health Experience Named Agency of the Year at the 2022 Manny Awards

Press Release Apr 25, 2022

Microbiologics Acquires Cryologics

Press Release Apr 25, 2022

Pano Therapeutics, Inc. Announces the Strategic Acquisition of NovaTarg Therapeutics, Inc. and the Appointment of Ken Batchelor, PhD, as Head of Research & Development

Press Release Apr 22, 2022

SERUM X - a New, Innovative Form of Topical Pain Relief With Powerful Super-Antioxidant Action From New Biotech AO Biologix

"SERUM X is the ultimate game changer for those with nagging pain. I can't wait for the world to try it," says co-creator Dan Purser MD. Read More

Press Release Apr 20, 2022

InvestChile Promotes Pharmaceutical Companies Landing in South America's Business Hub

The agency has published an e-book with a step-by-step operating guide that details the benefits for international companies of setting up in the Southern Cone country. Read More

Press Release Apr 19, 2022

Scailyte's 5th Anniversary Mini-Symposium - Machine Learning Meets Multi-Omics for Precision Medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics powered by machine learning for precision medicine. Read More

Press Release Apr 12, 2022

The Story Behind Sambrosa's Perfectly Blended Allergy Nighttime Syrup

Before Sambrosa's perfectionated sleep syrup was a bestselling product, it was the work of a homeopathic doctor committed to helping her patients get higher-quality rest Read More

Press Release Apr 11, 2022

Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis

Press Release Apr 11, 2022

Cellvera Supports Oxford University and the UK Department of Health and Social Care With Expansion of the PRINCIPLE Trial

PRINCIPLE has been the UK Government's national priority platform trial of COVID-19 treatments, and one of the world's largest currently taking place in an outpatient setting Read More

Press Release Apr 8, 2022

Consortium of Japanese Energy Companies Acquire 50 MW Tahara Biomass Project From Solariant Capital

Press Release Apr 5, 2022

EZEN Partners With ComplianceQuest to Support Clients' Digital Transformation

Press Release Apr 4, 2022

Clinical Outcomes Solutions and FingerPost Mark Five Years of Collaboration Dedicated to Informing the COA Competitive Landscape in the Anti-Cancer Therapy Space

Press Release Mar 30, 2022

LTO Network Becomes the World's Premier Blockchain Network for eClinical Applications Through the Partnership of Triall With Crucial Data Solutions

LTO Network announces that through its collaboration with integrator Sphereon, it will host the world's next generation of eClinical data. Triall will integrate its blockchain APIs with the eClinical solutions of CDS, realizing the world's first end-to-end eClinical platform powered by blockchain. Read More

Press Release Mar 29, 2022

Ebvia Announces Positive Results Published in Nature for TMPRSS2 Inhibitor for the Prevention and Treatment of COVID-19

A Novel, Simple-to-Use, Outpatient Nasal Spray for COVID-19 and Influenza in Development Read More

Press Release Mar 29, 2022

Longwood Fund Announces Longwood Healthcare Leaders, a Web Conference for Industry Leaders, on May 4-5, 2022

Press Release Mar 21, 2022

Tadgh Prendeville to Assume the Role of President and CEO at Regis Technologies, Inc.

Press Release Mar 21, 2022

Vivacitas Oncology Appoints Harvard Professor of Medicine Dr. David Reardon, MD to the Company's Neuro-Oncology Medical Advisory Board

Press Release Mar 15, 2022

Philogen SpA - Notice of Full Year 2021 Results

Press Release Mar 14, 2022

Almac Pharma Services Expands Its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products

Tailored service enables processing and QP release within 20 hours Read More